Ravasio, R.; Antonelli, S.; Maiorino, A.; Costanzo, A.; Losi, S. Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-to-Severe Plaque Psoriasis in Italy. Grhta 2019, 6.